Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
Ari Green(University of California, San Francisco), Jeffrey M. Gelfand(University of California, San Francisco), Bruce Cree(University of California, San Francisco), Carolyn Bevan(University of California, San Francisco), W. John Boscardin(University of California, San Francisco), Feng Mei(University of California, San Francisco), Justin Inman(University of California, San Francisco), Sam Arnow(University of California, San Francisco), Michael Devereux(University of California, San Francisco), Aya Abounasr(University of California, San Francisco), Hiroko Nobuta(Broad Institute), Alyssa H. Zhu(University of California, San Francisco), Matt Friessen(University of California, San Francisco), Roy Gerona(University of California, San Francisco), H.‐Christian von Büdingen(University of California, San Francisco), Roland G. Henry(University of California, San Francisco), Stephen L. Hauser(University of California, San Francisco), Jonah R. Chan(University of California, San Francisco)
Cited by 570Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis